Literature DB >> 18056431

The guardian's little helper: microRNAs in the p53 tumor suppressor network.

Xingyue He1, Lin He, Gregory J Hannon.   

Abstract

Several microRNAs (miRNAs) have been implicated in tumor development based on both changes in their expression patterns and gene structural alterations in human tumors. However, we are only now beginning to see how miRNAs interact with classic oncogene and tumor suppressor mechanisms. Several recent studies have implicated the miR-34 family of miRNAs in the p53 tumor suppressor network. The expression of miR-34a, miR-34b, and miR-34c is robustly induced by DNA damage and oncogenic stress in a p53-dependent manner. When overexpressed, miR-34 leads to apoptosis or cellular senescence, whereas reduction of miR-34 function attenuates p53-mediated cell death. These findings, together with the fact that miR-34 is down-regulated in several types of human cancer, show that miRNAs can affect tumorigenesis by working within the confines of well-known tumor suppressor pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056431     DOI: 10.1158/0008-5472.CAN-07-2672

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  137 in total

Review 1.  Emerging paradigms of regulated microRNA processing.

Authors:  Martin A Newman; Scott M Hammond
Journal:  Genes Dev       Date:  2010-06-01       Impact factor: 11.361

2.  Downregulation of cell cycle-related proteins in ovarian cancer line and cell cycle arrest induced by microRNA.

Authors:  Jian-Mei Yuan; Xue-Jun Shi; Ping Sun; Jun-Xia Liu; Wei Wang; Ming Li; Feng-Yu Ling
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a.

Authors:  Qing-Rong Chen; Li-Rong Yu; Patricia Tsang; Jun S Wei; Young K Song; Adam Cheuk; Joon-Yong Chung; Stephen M Hewitt; Timothy D Veenstra; Javed Khan
Journal:  J Proteome Res       Date:  2010-12-23       Impact factor: 4.466

4.  p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest.

Authors:  Christian J Braun; Xin Zhang; Irina Savelyeva; Sonja Wolff; Ute M Moll; Troels Schepeler; Torben F Ørntoft; Claus L Andersen; Matthias Dobbelstein
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

5.  The Effect of Newly Synthesized Heterosteroids on miRNA34a, 98, and 214 Expression Levels in MCF-7 Breast Cancer Cells.

Authors:  Shaymaa M M Yahya; Gamal A Elmegeed; Mervat S Mohamed; Rafat M Mohareb; Mervat M Abd-Elhalim; Ghada H Elsayed
Journal:  Indian J Clin Biochem       Date:  2017-07-26

Review 6.  The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma.

Authors:  Xiaoping Luo; Nasser Chegini
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

Review 7.  MicroRNA signature and regulatory functions in the endometrium during normal and disease states.

Authors:  Qun Pan; Nasser Chegini
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

Review 8.  Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics.

Authors:  Marc S Weinberg; Matthew J A Wood
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

9.  Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.

Authors:  Mohd W Nasser; Jharna Datta; Gerard Nuovo; Huban Kutay; Tasneem Motiwala; Sarmila Majumder; Bo Wang; Saul Suster; Samson T Jacob; Kalpana Ghoshal
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

Review 10.  The first 30 years of p53: growing ever more complex.

Authors:  Arnold J Levine; Moshe Oren
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.